EXOXEMIS
Microbiological infection caused by bacteria, viruses, fungi, and prions is an important concern in a range of healthcare sectors affecting human health and well-being. Safe and effective microbicidal products are especially critical today, when antimicrobial resistance and the potential for the rapid spread of pathogens have become public-health issues in countries throughout the world. For 20 years, Exoxemis, Inc. has been the leader in the development of broad-spectrum haloperoxidase-based... products for use in high-value product areas, including a biological entity for use in high morbidity/mortality applications. They are committed to integrating their technology with the intellectual, financial, and commercial strengths of prospective partners to develop innovative products and long-term relationships.
EXOXEMIS
Industry:
Biopharma Biotechnology Medical
Founded:
1985-01-01
Address:
Arkansas City, Arkansas, United States
Country:
United States
Website Url:
http://www.exoxemis.com
Total Employee:
11+
Status:
Active
Contact:
15016032270
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Font Awesome
Similar Organizations
Official Site Inspections
http://www.exoxemis.com Semrush global rank: 5.43 M Semrush visits lastest month: 1.56 K
- Host name: host01.alaskapackers.com
- IP address: 72.52.158.167
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Exoxemis"
About Us - Exoxemis - a biomedical research company focused on …
Exoxemis is a privately held company that draws from academia, private industry, and government to maximize competitiveness, innovation, and intellectual capital.See details»
Exoxemis - Crunchbase Company Profile & Funding
For 20 years, Exoxemis, Inc. has been the leader in the development of broad-spectrum haloperoxidase-based products for use in high-value product areas, including a biological …See details»
Exoxemis, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Exoxemis, Inc. with its drug pipeline, therapeutic area, technology platform, 12 literature, Disease Domain:Infectious Diseases, Technology Platform ...See details»
EXOXEMIS, INC. Company Profile | Omaha, NE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EXOXEMIS, INC. of Omaha, NE. Get the latest business insights from Dun & Bradstreet.See details»
EXOXEMIS, INC. Company Profile | Little Rock, AR | Competitors ...
Exoxemis, inc. d&b business directory home / business directory / wholesale trade / merchant wholesalers, nondurable goods / drugs and druggists' sundries merchant wholesalers / united …See details»
Contact-US - Exoxemis - a biomedical research company focused …
Exoxemis, Inc. P.O. Box 7570 Little Rock AR 72217. We welcome inquiries regarding our company, licensing, alliances and product development. For more information, please contact …See details»
exoxemis.com - Home - Exoxemis - a biomedical... - Exoxemis
Popular pages. Home - Exoxemis - a biomedical research company focused on the study and commercialization of a. Exoxemis is a biomedical research company Focused on the study …See details»
Exoxemis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
A biopharmaceutical research and development company, develops haloperoxidase products for prevention and treatment of serious infections.See details»
Exoxemis - Crunchbase
A biopharmaceutical research and development company, develops haloperoxidase products for prevention and treatment of serious infections.See details»
Exoxemis - Overview, News & Competitors | ZoomInfo.com
Exoxemis - Business Information. Business Services · Arkansas, United States · <25 Employees. Exoxemis, Inc. (Little Rock, Arkansas) presents research results comparing the …See details»
Exoxemis - Company Profile - Tracxn
Oct 20, 2024 Exoxemis is a developer of enzymatic therapeutics for infections caused by bacteria, viruses, fungi, and prions. The company is using Myeloperoxidase (MPO) and …See details»
Exoxemis Careers and Employment | Indeed.com
Find out what works well at Exoxemis from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read …See details»
Exoxemis - Products, Competitors, Financials, Employees, …
Exoxemis is a biomedical research company focused on the development and commercialization of a topical biological antiseptic system in the healthcare sector. Use the CB Insights Platform …See details»
Vision - Exoxemis - a biomedical research company focused on …
Exoxemis’ MPO system offers an alternative platform from which to build a new series of effective products based upon natural host defense mechanisms. This novel approach is effective …See details»
Jackson Stephens - Wikipedia
Jackson Thomas "Steve" Stephens Jr (born July 24, 1952) is an American businessman and the founder, chairman, and CEO of Exoxemis, Inc., a biomedical research company. [1] He is the …See details»
Groundbreaking Research Points Towards Exoxemis ... - Business …
Oct 2, 2019 “Exoxemis is the only biomedical research company in the world that has been able to make MPO in large, pure quantities at a price that makes it suitable for commercial use …See details»
Technology - Exoxemis - a biomedical research company focused …
Exoxemis has created a broad proprietary base of predictive models, know-how, and intellectual property that form the foundation for commercialization efforts. Extensive in vitro and in vivo …See details»
Groundbreaking Research Points Towards Exoxemis’ Zempia
Groundbreaking Research Points Towards Exoxemis’ Zempia ... - BioSpaceSee details»
Publications - Exoxemis - a biomedical research company focused …
A novel enzyme system utilizing myeloperoxidase (MPO) as a potent antimicrobial agent has been developed (Exoxemis, Inc. Little Rock, AR). The MPO system demonstrated both rapid …See details»